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Introduction
Hepatocellular carcinoma (HCC) is the 5th commonest 
cancer among adult men and the 7th among women. It is 
the second most common cause of cancer related deaths 
in the world [1]. In terms of aetiology, it had been shown 
that almost 80% of global HCC is related to chronic 
hepatitis B and C infections [2]. This gets us to question 
the prevalence and distribution of these two viruses. It is 
argued that the prevalence of HCC is determined by the 
geographical distribution of these two viruses and the age 
of acquisition. For example, in the West, the commonest 
causes of HCC are alcohol related cirrhosis and hepatitis 
C (due to intravenous drug injection) which are all related 
to older age while in the developing world, the commonest 
cause is Hepatitis B virus which is mainly acquired 
vertically (thus the importance of age of acquisition) and 
aflatoxin which are related to early exposure. This is further 
aggravated by the lack of wide Hep B vaccine coverage in 
the developing world (Sub Saharan Africa) in the past. 
However, horizontal transmission of Hepatitis B is also 
on the rise in the developing world among children due to 
salivary viral shedding while playing with each other. Also, 
improper/incomplete sterilization of barbers’ shavers is 
another reason for the horizontal transmission among 
adults in the developing world. Although this partially 
explains the high Hep B related HCC in the developing 
world, alcohol is also seen to be rising as a potential cause 
of cirrhosis and thus, HCC in this part of the world [5].  
In South Sudan, there are no data showing prevalence 
of HCC or its related risk factors such as hepatitis, alcohol 
consumption and many others.
Causes of HCC
It is worth noting that 80-90% of HCC present in 
the background of cirrhosis [3]. So, what are the causes 
of cirrhosis and which ones are common in South Sudan? 
It is literally proven that any condition that can lead to 
cirrhosis of the liver can cause HCC. These conditions 
include (but not limited to):
• Chronic Hepatitis B and C viruses
• Aflatoxins
• Excessive alcohol consumption
• Moderate alcohol consumption in a background  




• Right sided heart failure
• Alpha 1 antitrypsin deficiency
• Primary biliary cirrhosis
• Primary sclerosing cholangitis 
• Tyrosinosis
Sube et al. determined the co-infection rate between 
HIV and Hepatitis B and C among blood donors in Juba 
Teaching Hospital to be 50% and 18% respectively [4]. 
Hepatocellular carcinoma is one of the common malignancies in both the developed and developing worlds. 
This is most likely due to its wide variety of causes. The aetiologies vary from one part of the world to another 
determined by many factors ranging from geography, life style, availability of advanced medical care etc among 
many others. Though the presentation and diagnosis of hepatocellular carcinoma is straight forward in many 
developed countries, the reality is different in many resource-constrained regions and countries such as South 
Sudan which has only one Computer-Tomography machine country wide, lack of most of the non-invasive liver 
screening tests as well as coupled with lack of medical personnel. However, in spite of these challenges, the 
authors of this article believe that the diagnosis of hepatocellular carcinoma can be reasonably made considering 
the clinical presentation of this condition and maximizing the use of available diagnostic tools. 
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Although they pinned this down to the common modes 
of transmission of these viruses, it is worth mentioning 
that these are high prevalence among healthy population 
attending for blood donation. Out of clinical experience in 
South Sudan, one can tell that the prevalence of Hepatitis 
B and C viruses is high with the former much common 
than the later. This is a grey area calling for a country-wide 
research. This high prevalence could be explained by the 
lack of vaccination (for Hep B) in the past for children due 
to the civil war which rendered many parts of the country 
inaccessible. Not only is that, the avoidance of vaccination 
in the past by communities due to surrounding myths as 
well can explain this. Therefore, there is a clear need for 
urgent studies to determine the prevalence of the possible 
causes of liver cirrhosis and thus, HCC in South Sudan.
Clinical presentation
Depending on the cause of HCC, patients can 
present slightly differently. However, keeping in mind 
that 80-90% of HCC occur in cirrhotic patients, then 
presentation mimics that of cirrhosis and could be in 
form of cachexia, jaundice, rapid ascites (due to portal 
vein thrombosis given that HCC like any other cancer 
is a pro thrombotic condition), pruritus (due to ductal 
compression), finger clubbing, right upper quadrant pain, 
variceal bleeding (hematemesis and/or melaena) etc.  On 
the other hand, HCC can be an incidental finding on an 
US scan of an abdomen done for unrelated complains. 
This is rare though. 
Investigating HCC
For every jaundice or liver mass (on examination) of 
unknown cause, it is always worth performing the routine 
investigations plus the Non Invasive Liver Screening . The 
routine tests include: FBCs, Urea and Electrolytes, LFTs 
and coagulation. These could offer a hint on the possible 
aetiology or performance status. For example, raised MCV 
(alcohol?), very high WCC (Leukaemia? Infection?), 
thrombocytopenia (alcohol? portal hypertension?), raised 
urea and creatinine (hepatorenal syndrome?), very high 
GGT (HCC?, Alcohol?),  deranged coagulation (failing 
liver? DIC?), very high AST and ALT (Ischaemic liver? 
Paracetamol overdose?), low platelets and high INR 
(reconsider liver biopsy?)
Non-Invasive Liver Screening Tests (NILS) include: 
• Liver auto antibodies: AMA, Gastric parietal cell, 
LKM antibody and Smooth muscle antibody.
• Immunoglobulin G,A and M: Looking for 
autoimmune hepatitis
• 24 hr urinary copper and serum ceruplasmin: In 
those under 40 yrs looking for Wilson’s disease
• Alpha 1 antitrypsin level: Looking for a low level
• Alpha fetoprotein: When there is a mass on 
imaging 
• Hepatitis B and C. Can cause both acute and 
chronic liver disease though acute presentation is 
rare in C. 
• Hepatitis A, CMV, EBV and Adenovirus: For 
acute jaundice only. They don’t cause chronic 
liver problems. In South Sudan, most people are 
immune to these.
• Serum ferritin level: If high (supported with 
clinical features), think of HFE gene
• Serum lipids: If you are thinking of NAFLD
• US abdomen: Liver, spleen, gall bladder, CBD, 
ascites, PV, HV, head of pancreas, etc. On finding 
a low attenuating hepatic lesion on US, there 
should be a high index of suspicion for a HCC 
and thus, an alpha fetoprotein and CT chest, 
abdomen (liver) and pelvis should be requested 
to clearly define the liver lesion(s) and establish 
any metastases. However, a definite diagnosis of 
an HCC is histological. Tissue is usually obtained 
by an US guided liver biopsy which is safer than a 
blind intervention. [6]
Diagnostic challenges in South Sudan
South Sudan has very limited tests to investigate 
HCC and its possible cause(s) beside hepatitis serology, 
ultrasound and a CT (only found in one private facility). 
There is an absence of all the other relevant tests and only 
two pathologists in the country (when thinking of biopsy). 
Some private facilities can perform the AFP titres as well. 
This is the reality at the time of writing and publishing 
this article. These limited resources make it hard (but not 
impossible) to reasonably diagnose HCC and determine 
a possible cause. A strong clinical sense (supported by 
detailed history and examination) with a maximum use 
of the available limited resources should allow this to 
happen though undoubtedly, we shall be missing out 
some aetiologies for HCC.   So, the authors of this article 
are saying, US, AFP, LFTs, viral hepatitis serology and a 
good clinical approach should pick up most of the HCC 
cases and determine their viral causes. 
Treatment modalities
Definitive curative treatments for HCC are either 
hepatic resection or liver transplantation. This entirely 
depends on the size, number and spread (metastasis) 
of the cancer.  This is outside the scope of this article. 
However, it is worth mentioning that all patients with a 
HCC (non metastatic) be referred to specialist care ( non-
existent  in South Sudan) immediately as some of them 
could benefit from interventions such as Radiofrequency 
ablation (RFA), Trans-arterial Chemoembolization 
(TACE), resection or transplant. 
For those with clear metastatic disease, it is worth 
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offering specialist option as well for palliative purposes. 
All these treatment options are currently missing in 
South Sudan and therefore, it is worth to critically think 
and maximally involve patients in deciding the balance 
between the costs of foreign travelling and medical care/
outcome expected to that of remaining at home and 
spending quality time with family.
Conclusions and ways forward
From the review of articles and the possible causes 
and prevalence of HCC, it is clear that South Sudan 
is a country in a belt with a high risk of HCC. It is 
therefore worth investigating patients with suspicious 
liver lesions on imaging or liver enzymes. It is also worth 
maximizing our clinical senses in obtaining detailed risk 
history (to complement our limited investigations) as 
well as maximally using the available resources. Research 
is definitely needed in this field to determine common 
causes of HCC in South Sudan and their distribution 
nation-wide. 
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